Antiphospholipid Syndrome and Cardiac Bypass: The Careful Balance between Clotting and Bleeding
J Extra Corpor Technol, 53 1 (2021) 46-49
Published online: 2021-03-15
Articles citing this article
The Citing articles tool gives a list of articles citing the current article.
The citing articles come from EDP Sciences database, as well as other publishers participating in CrossRef Cited-by Linking Program. You can set up your personal account to receive an email alert each time this article is cited by a new article (see the menu on the right-hand side of the abstract page).
Cited article:
This article has been cited by the following article(s):
Simulation-based activated clotting time targeting for cardiopulmonary bypass in patients with antiphospholipid syndrome: two case reports
Yuki Kamikawa, Yosuke Saito, Hiromi Fujii, Yoichiro Machida, Hiroaki Hata and Hirotaka InabaGeneral Thoracic and Cardiovascular Surgery Cases 4 (1) (2025)
https://doi.org/10.1186/s44215-025-00235-0
Walking the Tightrope: Anticoagulation Management of Patients with Antiphospholipid Syndrome and Immune Thrombocytopenic Purpura Undergoing Mitral Valve Replacement With Cardiopulmonary Bypass
Boran Katunaric and Brent BoettcherJournal of Cardiothoracic and Vascular Anesthesia 38 (11) 2731 (2024)
https://doi.org/10.1053/j.jvca.2024.07.014
Efficacy of the Hepcon system in reducing hemorrhagic and thrombotic complications in antiphospholipid syndrome patients undergoing cardiac surgery
Sheu Michael, Molina Garcia Sofia, Wei Wei, Grady Patrick, Apostolakis John and Angelini DanaPerfusion 39 (7) 1424 (2024)
https://doi.org/10.1177/02676591231197990